Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Palvella Therapeutics, Inc.
Market Cap
$1.84B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$1.83B
Net Profit Margin
1.05%
TTM Avg
1.42%
3Y Avg
2.79%
5Y Avg
2.28%
Market Cap
$1.83B
Net Profit Margin
-6.93%
TTM Avg
-10.04%
3Y Avg
-34.65%
5Y Avg
-50.14%
Market Cap
$1.85B
Net Profit Margin
-3059.99%
TTM Avg
-3150.18%
3Y Avg
-1765.57%
5Y Avg
-1177.05%
Market Cap
$1.81B
Net Profit Margin
-20.02%
TTM Avg
-19.08%
3Y Avg
-29.38%
5Y Avg
-13.21%
Market Cap
$1.86B
Net Profit Margin
-59.87%
TTM Avg
5.85%
3Y Avg
-31.86%
5Y Avg
-479.70%
Market Cap
$1.81B
Net Profit Margin
25.02%
TTM Avg
21.58%
3Y Avg
17.87%
5Y Avg
17.55%
Market Cap
$1.81B
Net Profit Margin
-155.59%
TTM Avg
-141.87%
3Y Avg
-98.38%
5Y Avg
-69.99%
Market Cap
$1.87B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Palvella Therapeutics, Inc. (PVLA) | $1.84B | 0.00% | 0.00% | 0.00% | N/A |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 1.05% | 1.42% | 2.79% | 2.28% |
| Sarepta Therapeutics, Inc. (SRPT)vs › | $1.83B | -6.93% | -10.04% | -34.65% | -50.14% |
| Immunome, Inc. (IMNM)vs › | $1.85B | -3059.99% | -3150.18% | -1765.57% | -1177.05% |
| Azenta, Inc. (AZTA)vs › | $1.81B | -20.02% | -19.08% | -29.38% | -13.21% |
| Novavax, Inc. (NVAX)vs › | $1.86B | -59.87% | 5.85% | -31.86% | -479.70% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.81B | 25.02% | 21.58% | 17.87% | 17.55% |
| Xencor, Inc. (XNCR)vs › | $1.81B | -155.59% | -141.87% | -98.38% | -69.99% |
| Trevi Therapeutics, Inc. (TRVI)vs › | $1.87B | 0.00% | 0.00% | 0.00% | 0.00% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 49.06% | -18.57% | -80.13% | -53.74% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | -352.89% |
| 2023-09-30 | -55.08% |
| 2023-06-30 | 19.83% |
| 2023-03-31 | -680.94% |
